Compounds > 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine
Page last updated: 2024-09-03

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and oseltamivir

4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine has been researched along with oseltamivir in 1 studies

Compound Research Comparison

Studies
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Trials
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Recent Studies (post-2010)
(4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine)		Studies
(oseltamivir)		Trials
(oseltamivir)		Recent Studies (post-2010) (oseltamivir)
6003,3681862,014

Protein Interaction Comparison

ProteinTaxonomy4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine (IC50)oseltamivir (IC50)
Neuraminidase Influenza A virus (A/Turkey/651242/2006(H5N1))0.1104
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))0.2616
Neuraminidase Influenza A virus (A/duck/Laos/25/2006(H5N1))2.0317
NeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))1.1344
NeuraminidaseInfluenza A virus (A/USSR/90/1977(H1N1))0.002
NeuraminidaseInfluenza B virus (B/Lee/1940)0.005
Acyl-CoA desaturase 1Mus musculus (house mouse)0.008
Neuraminidase Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1))0.0043
Neuraminidase Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1))0.0003
NeuraminidaseInfluenza A virus (A/Singapore/1/1957(H2N2))0.003
NeuraminidaseInfluenza A virus (A/Aichi/2/1968(H3N2))0.0016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1

Other Studies

1 other study(ies) available for 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and oseltamivir

ArticleYear
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009